Sector Update: Health Care Stocks Advance Premarket Friday
Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved
Express News | Amneal Pharmaceuticals Inc - FDA Review of Dhe Autoinjector Nda Expected by Q2 2025
Express News | Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
Truist Financial Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating
105642463xu : $KULR Technology (KULR.US)$
Jaguar8 OP 105642463xu : Yup its on my watchlist
Rosscco : Thanks for the tip !
Adria87 : Thank You for the tip
baqklin : not a good play if 66% is moved to dark pool?